Work

PB1277 Precision and Reproducibility of New Automated Chemiluminescent Immunoassays (CLIA) for the Detection of Antiphospholipid IgM Antibodies

Year: 2026

Type: conference-abstract

Abstract: Two new, fully automated, CLIA assays (HemosIL CL Anti-Cardiolipin IgM [CL aCL IgM] and HemosIL CL Anti-β2 Glycoprotein-I IgM [CL aβ2GPl IgM) have been developed for the ACL TOP 970 CL. The ACL TOP 970 CL is the first and only automated system to include all Antiphospholipid Syndrome (APS) guideline recommended assays within single instrument. HemosIL CL aCL IgM and CL aβ2GPl IgM are intended to aid in the diagnosis of APS when used in conjunction with other laboratory and clinical findings. Precision and reproducibility for the new assays were established in a two-part study.

Source: Research and Practice in Thrombosis and Haemostasis

DOI: 10.1016/j.rpth.2026.104139

Authors: Niki Leonard, Ashley Moraski

Institutions: Werfen (Spain), Werfen Immunoassay Technology Center, Werfen (United States)

Language: English

Topic: Systemic Lupus Erythematosus Research

Subfield: Rheumatology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: gold

Estimated APC paid: $2,250

OpenAlex ID: W7220362623

Cites:

Cited by:

Related to: 10